SMART IBD 移动应用改善儿童炎症性肠病自我管理的试点和可行性。
Pilot and feasibility of the SMART IBD mobile app to improve self-management in pediatric inflammatory bowel disease.
机构信息
Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Center for Adherence and Self-Management, Cincinnati, Ohio, USA.
Department of Pediatrics, University of Cincinnati College of Medicine, Birmington, Alabama, USA.
出版信息
J Pediatr Gastroenterol Nutr. 2024 Jun;78(6):1273-1278. doi: 10.1002/jpn3.12229. Epub 2024 Apr 29.
OBJECTIVES
Access to evidence-based self-management support in pediatric inflammatory bowel disease (IBD) is a significant challenge. Digital therapeutic solutions can increase access and provide data to patients and providers that would otherwise not be available. We have iteratively developed a mobile application, Self-Management Assistance with Recommended Treatment (SMART) IBD, that allows patients to access self-management support and record symptoms and medication adherence.
METHODS
We conducted a pilot and feasibility study for this digital therapeutic tool in which patients used SMART IBD for 30 days.
RESULTS
Results indicated that patients rated the app quality as good and accessed the app adequately overall, with some pages being used often. Medication adherence increased over the course of the study and was associated with sleep duration, mood, and stool consistency and blood content.
CONCLUSIONS
Overall, this study demonstrated adequate feasibility for the SMART IBD app and initial findings suggest that additional research is needed to explore the potential impact of this tool in clinical care.
目的
在小儿炎症性肠病（IBD）中获得基于证据的自我管理支持是一项重大挑战。数字治疗解决方案可以增加获取途径，并为患者和提供者提供否则无法获得的数据。我们已经反复开发了一个移动应用程序，即推荐治疗自我管理辅助（SMART）IBD，它允许患者获得自我管理支持，并记录症状和药物依从性。
方法
我们对该数字治疗工具进行了一项试点和可行性研究，其中患者使用 SMART IBD 达 30 天。
结果
结果表明，患者总体上对应用程序质量评价良好，且能充分使用该应用程序，一些页面经常被使用。在研究过程中，药物依从性增加，且与睡眠时长、情绪、粪便稠度和血液含量有关。
结论
总体而言，本研究证明了 SMART IBD 应用程序具有足够的可行性，初步结果表明需要进一步研究来探索该工具在临床护理中的潜在影响。
Zotero 插件